The Relationship Between Systemic Lupus Erythematosus and Osteoporosis Based on Different Ethnic Groups: a Two-Sample Mendelian Randomization Analysis
- PMID: 38355832
- DOI: 10.1007/s00223-024-01190-8
The Relationship Between Systemic Lupus Erythematosus and Osteoporosis Based on Different Ethnic Groups: a Two-Sample Mendelian Randomization Analysis
Abstract
The previous observational studies could not overcome the effects of confounding variables and reverse causality. We aimed to determine whether there is a causal relationship between systemic lupus erythematosus and osteoporosis in East Asian and European populations, respectively, by two-sample Mendelian Randomization analysis. We obtained and downloaded data from publicly available genome-wide association study databases and analyses for East Asian and European populations, including systemic lupus erythematosus (SLE), osteoporosis (OP), multisite bone mineral density (BMD), and OP with fracture. After screening for instrumental single-nucleotide polymorphisms (SNPs) significantly correlated to SLE, the inverse-variance weighted (IVW) method was used for calculating the ratio and 95% confidence interval, besides utilizing MR-Egger, weighted median, and weighted mode to assess the robustness of the primary outcome. Moreover, multiple analyses, including MR-PRESSO, MR-Egger intercept, Cochran's Q test, as well as "leave-one-out" sensitivity, were used for evaluating horizontal pleiotropy, heterogeneity, and stability. Finally, we exchanged exposure and outcome and performed a reverse MR analysis. IVW (OR = 1.05, 95% CI = 1.01-1.09, P = 0.009) indicated a significant positive correlation between genetically predicted SLE and OP in East Asians. Furthermore, neither heterogeneity nor horizontal pleiotropy was observed. In Europe, there was no significant genetically predicted causal relation between SLE and OP. Bi-directional MR analysis showed no reverse causality between SLE and OP. In the East Asian population, genetically predicted SLE may have had a positive causal relationship with OP. In Europe, there is insufficient evidence for a potential causal relation between SLE and OP or BMD and fracture, and the correlations currently observed may be attributed to a variety of confounder variables.
Keywords: Mendelian randomization; Osteoporosis; Systemic lupus erythematosus.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study.Clin Rheumatol. 2023 Dec;42(12):3237-3249. doi: 10.1007/s10067-023-06700-x. Epub 2023 Jul 26. Clin Rheumatol. 2023. PMID: 37495778
-
[Genetic Causation Analysis of Hyperandrogenemia Testing Indicators and Preeclampsia].Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 May 20;55(3):566-573. doi: 10.12182/20240560106. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38948277 Free PMC article. Chinese.
-
Association between systemic lupus erythematosus and osteoporosis: a mendelian randomization analysis.BMC Rheumatol. 2024 May 6;8(1):17. doi: 10.1186/s41927-024-00388-5. BMC Rheumatol. 2024. PMID: 38711124 Free PMC article.
-
Plasma proteins, circulating metabolites mediate causal inference studies on the effect of gut bacteria on the risk of osteoporosis development.Ageing Res Rev. 2024 Nov;101:102479. doi: 10.1016/j.arr.2024.102479. Epub 2024 Aug 28. Ageing Res Rev. 2024. PMID: 39214170 Review.
-
Osteoporosis and Primary Biliary Cholangitis: A Trans-ethnic Mendelian Randomization Analysis.Clin Rev Allergy Immunol. 2024 Apr;66(2):138-148. doi: 10.1007/s12016-024-08986-4. Epub 2024 Mar 30. Clin Rev Allergy Immunol. 2024. PMID: 38554235 Review.
Cited by
-
Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2025 Jan 16;15:1486188. doi: 10.3389/fendo.2024.1486188. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39886030 Free PMC article.
References
-
- Chin KY, Ng BN, Rostam MKI, Muhammad Fadzil NFD, Raman V, Mohamed Yunus F, Syed Hashim SA, Ekeuku SO (2022) A Mini review on osteoporosis: from biology to pharmacological management of bone loss. J Clin Med 11(21):6434. https://doi.org/10.3390/jcm11216434 - DOI - PubMed - PMC
-
- Zhu X, Bai W, Zheng H (2021) Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications. Bone Res 9(1):23. https://doi.org/10.1038/s41413-021-00143-3 - DOI - PubMed - PMC
-
- Huang X, Zhang Q, Zhang H, Lu Q (2022) A contemporary update on the diagnosis of systemic lupus erythematosus. Clin Rev Allergy Immunol 63(3):311–329. https://doi.org/10.1007/s12016-021-08917-7 - DOI - PubMed
-
- Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17(10):642. https://doi.org/10.1038/s41584-021-00690-3 - DOI - PubMed
-
- Xia J, Luo R, Guo S, Yang Y, Ge S, Xu G, Zeng R (2019) Prevalence and risk factors of reduced bone mineral density in systemic lupus erythematosus patients: a meta-analysis. Biomed Res Int 2019:3731648. https://doi.org/10.1155/2019/3731648 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
